DMD and Duchenne muscular dystrophy: Intramuscularly administrating SpCas9 or SaCas9 components in DMD mdx4Cv mice repairs dystrophin protein expression in up to 68% of skeletal myofibers, improves skeletal muscle structure, and boosts muscle forces [128].